Search Legislation

Commission Directive 2009/2/ECShow full title

Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

ANNEX 1BU.K.

Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

440-620-2920-36-5

F; R15-17

R14

C; R35

R67

N; R50-53

F; C; N

R: 14/15-17-35-67-50/53

S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61

005-013-00-5diethylmethoxyborane425-380-97397-46-8

F; R17

Xn; R20/21/22-48/22

C; R34

R43

R53

F; C

R: 17-20/21/22-34-43-48/22-53

S: (1/2-)6-26-36/37/39-43-45-61

005-014-00-04-formylphenylboronic acid438-670-587199-17-5R43

Xi

R: 43

S: (2-)24-37

005-017-00-7

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-37-41-62

22 % ≤ C < 25 %: T; R61-37-41-62

20 % ≤ C < 22 %: T; R61-36/37-62

14 % ≤ C < 20 %: T; R61-36-62

9 % ≤ C < 14 %: T; R61-62

6,5 % ≤ C < 9 %: T; R61

005-017-01-4

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T; R23

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-23-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-23-37-41-62

22 % ≤ C < 25 %: T; R61-20-37-41-62

20 % ≤ C < 22 %: T; R61-20-36/37-62

14 % ≤ C < 20 %: T; R61-20-36-62

9 % ≤ C < 14 %: T; R61-20-62

6,5 % ≤ C < 9 %: T; R61-20

3 % ≤ C < 6,5 %: Xn; R20

005-018-00-2

perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R37-41

T

R: 61-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-37-41-62

22 % ≤ C < 36 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

005-018-01-X

perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R20

Xi; R37-41

T

R: 61-20-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-20-37-41-62

25 % ≤ C < 36 %: T; R61-20-36/37-62

22 % ≤ C < 25 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36-61

006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0

Xn; R22-48/22

Xi; R41

R43

Xn

R: 22-41-43-48/22

S: (2-)22-26-36/37/39

006-099-00-7

N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;

3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate

432-520-2232938-43-1N; R51-53

N

R: 51/53

S: 22-61

006-101-00-6

mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;

N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]

423-070-8R53

R: 53

S: 61

006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamateE432-750-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R22-48/22

R43

N; R51-53

T; N

R: 45-46-22-43-48/22-51/53

S: 53-45-61

006-103-00-7 N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea445-760-8

Xi; R41

R42

N; R50-53

Xn; N

R: 41-42-50/53

S: (2-)22-26-39-45-60-61

C ≥10 %: Xn, N; R41-42-50/53

5 % ≤ C < 10 %: Xn, N; R36-42-50/53

1 % ≤ C < 5 %: Xn, N; R42-50/53

0,25 % ≤ C < 1 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 ≤ C < 0,025 %: R52/53

007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9

Xn; R21/22

C; R35

C

R: 21/22-35

S: (1/2-)26-36/37/39-45

012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1N; R50-53

N

R: 50/53

S: 60-61

014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6

Repr.Cat.2; R60

N; R50-53

T; N

R: 60-50/53

S: 53-45-60-61

C ≥ 0,5 %: T, N; R60-50/53

0,025 % ≤ C < 0,5 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

014-037-00-52-butanone-O,O′,O′′-(phenylsilylidyne)trioxime433-360-634036-80-1

Xn; R48/22

R43

R52-53

Xn

R: 43-48/22-52/53

S: (2-)36/37-61

014-038-00-0 S-(3-(triethoxysilyl)propyl)octanethioate436-690-9220727-26-4R43

Xi

R: 43

S: (2-)24-37

014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)24-37

014-042-00-2mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0Xi; R41

Xi

R: 41

S: (2-)26-39

014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2

F; R11

Xi; R37/38-41

R52-53

F; Xi

R: 11-37/38-41-52/53

S: (2-)6-26-36/39-61

014-044-00-33-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane433-050-0N; R51-53

N

R: 51/53

S: 61

014-045-00-9magnesium sodium fluoride silicate442-650-1Xn; R48/20

Xn

R: 48/20

S: (2-)22-36

015-190-00-0

bis(2,4-dicumylphenyl) neopentyl diphosphite;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

421-920-2154862-43-8R53

R: 53

S: 61

015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2

Xi; R38

R52-53

Xi

R: 38-52/53

S: (2-)37-61

015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3

T; R25

Xi; R41

N; R50-53

T; N

R: 25-41-50/53

S: (1/2-)26-39-45-60-61

015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

015-195-00-8

mixture of: potassium o-toluenephosphonate;

potassium m-toluenephosphonate;

potassium p-toluenephosphonate

433-860-4

Xi; R36

R43

R52-53

Xi

R: 36-43-52/53

S: (2-)24-26-37-61

015-196-00-3

mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

435-960-3

Carc.Cat.2; R45

Muta.Cat.2; R46

R43

T

R: 45-46-43

S: 53-45

015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7

R10

T; R23

Xn; R22

C; R34

N; R51-53

T; N

R: 10-22-23-34-51/53

S: (1/2-)9-26-36/37/39-45-61

015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1

Carc.Cat.3; R40

Xi; R41

Xn

R: 40-41

S: (2-)23-26-36/37/39

016-094-00-1sulfur231-722-67704-34-9Xi; R38

Xi

R: 38

S: (2-)46

016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3

Xn; R22

C; R34

R43

R52-53

C

R: 22-34-43-52/53

S: (1/2-)22-26-36/37/39-45-61

017-009-01-8

ammonium perchlorate;

[containing < 80 % of 0-30 μm particles]

T232-235-17790-98-9

E; R2

O; R9

E

R: 2-9

S: (2-)14-16-36/37

022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc.Cat.3; R40

Xn

R: 40

S: (2-)22-36/37

022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6

F; R11

C; R34

R43

R53

F; C

R: 11-34-43-53

S: (1/2-)6-9-16-26-36/37/39-45-61

028-002-01-4

nickel powder;

[particle diameter < 1 mm]

231-111-47440-02-0

Carc. Cat. 3; R40

T; R48/23

R43

R52-53

T

R: 40-43-48/23-52/53

S: (2-)36/37/39-45-61

028-013-00-7nickel matteE, H273-749-669012-50-6

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfateE295-859-392129-57-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53

20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53

2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-015-00-8slimes and sludges, copper electrolyte refining, decopperisedE, H305-433-194551-87-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 1; R61

Repr. Cat. 3; R62

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-62-68-50/53

S: 53-45-60-61

028-016-00-3

nickel diperchlorate;

perchloric acid, nickel(II) salt

E, H237-124-113637-71-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

C; R34

R42/43

N; R50-53

T; N

R: 49-61-34-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53

5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-017-00-9

nickel dipotassium bis(sulfate); [1]

diammonium nickel bis(sulfate) [2]

E, H

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-018-00-4

nickel bis(sulfamidate);

nickel sulfamate

E, H237-396-113770-89-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-019-00-Xnickel bis(tetrafluoroborate)E, H238-753-414708-14-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-021-00-0

nickel diformate; [1]

formic acid, nickel salt; [2]

formic acid, copper nickel salt [3]

E, H

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-022-00-6

nickel di(acetate); [1]

nickel acetate [2]

E, H

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-024-00-7nickel dibenzoateE, H209-046-8553-71-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-025-00-2nickel bis(4-cyclohexylbutyrate)E, H223-463-23906-55-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-026-00-8

nickel(II) stearate;

nickel(II) octadecanoate

E, H218-744-12223-95-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-027-00-3nickel dilactateE, H16039-61-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-028-00-9nickel(II) octanoateE, H225-656-74995-91-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat 2; R61

T; R48/23

C; R35

R42/43

N; R50-53

T; C; N

R: 49-61-35-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53

10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53

5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-029-00-4

nickel difluoride; [1]

nickel dibromide; [2]

nickel diiodide; [3]

nickel potassium fluoride [4]

E, H

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-030-00-Xnickel hexafluorosilicateE, H247-430-726043-11-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-031-00-5nickel selenateE, H239-125-215060-62-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-032-00-0

nickel hydrogen phosphate; [1]

nickel bis(dihydrogen phosphate); [2]

trinickel bis(orthophosphate); [3]

dinickel diphosphate; [4]

nickel bis(phosphinate); [5]

nickel phosphinate; [6]

phosphoric acid, calcium nickel salt; [7]

diphosphoric acid, nickel(II) salt [8]

E, H

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-033-00-6diammonium nickel hexacyanoferrateE, H74195-78-1

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-034-00-1nickel dicyanideE, H209-160-8557-19-7

Carc. Cat. 1; R49

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-32-42/43-48/23-50/53

S: 53-45-60-61

028-035-00-7nickel chromateE, H238-766-514721-18-7

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-036-00-2

nickel(II) silicate; [1]

dinickel orthosilicate; [2]

nickel silicate (3:4); [3]

silicic acid, nickel salt; [4]

trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

E, H

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-037-00-8dinickel hexacyanoferrateE, H238-946-314874-78-3

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-038-00-3

trinickel bis(arsenate);

nickel(II) arsenate

E, H236-771-713477-70-8

Carc. Cat. 1; R45

T; R48/23

R43

N; R50-53

T; N

R: 45-43-48/23-50/53

S: 53-45-60-61

028-039-00-9

nickel oxalate; [1]

oxalic acid, nickel salt [2]

E, H

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N: R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-040-00-4nickel tellurideE, H235-260-612142-88-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-041-00-Xtrinickel tetrasulfideE, H12137-12-1

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-042-00-5trinickel bis(arsenite)E, H74646-29-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-043-00-0

cobalt nickel gray periclase;

C.I. Pigment Black 25;

C.I. 77332; [1]

cobalt nickel dioxide; [2]

cobalt nickel oxide [3]

E, H

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-044-00-6

nickel tin trioxide;

nickel stannate

E, H234-824-912035-38-0

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-045-00-1nickel triuranium decaoxideE, H239-876-615780-33-3

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-046-00-7nickel dithiocyanateE, H237-205-113689-92-4

Carc. Cat. 1; R49

Muta. Cat. 3;R68

Repr. Cat. 2; R61

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-61-32-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-047-00-2nickel dichromateE, H239-646-515586-38-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1% ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-048-00-8nickel(II) seleniteE, H233-263-710101-96-9

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-049-00-3nickel selenideE, H215-216-21314-05-2

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-050-00-9silicic acid, lead nickel saltE, H68130-19-8

Carc. Cat. 1: R49

Repr. Cat. 1: R61

Repr. Cat. 3; R62

T; R48/23

R43

N; R50-53

T; N

R: 49-61-43-48/23-62-50/53

S: 53-45-60-61

028-051-00-4

nickel diarsenide; [1]

nickel arsenide [2]

E, H

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-052-00-X

nickel barium titanium primrose priderite;

C.I. Pigment Yellow 157;

C.I. 77900

E, H271-853-668610-24-2

Carc. Cat. 1: R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-053-00-5

nickel dichlorate; [1]

nickel dibromate; [2]

ethyl hydrogen sulfate, nickel(II) salt [3]

E, H

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T: R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-054-00-0

nickel(II) trifluoroacetate; [1]

nickel(II) propionate; [2]

nickel bis(benzenesulfonate); [3]

nickel(II) hydrogen citrate; [4]

citric acid, ammonium nickel salt; [5]

citric acid, nickel salt; [6]

nickel bis(2-ethylhexanoate); [7]

2-ethylhexanoic acid, nickel salt; [8]

dimethylhexanoic acid nickel salt; [9]

nickel(II) isooctanoate; [10]

nickel isooctanoate; [11]

nickel bis(isononanoate); [12]

nickel(II) neononanoate; [13]

nickel(II) isodecanoate; [14]

nickel(II) neodecanoate; [15]

neodecanoic acid, nickel salt; [16]

nickel(II) neoundecanoate; [17]

bis(D-gluconato-O 1,O 2)nickel; [18]

nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]

nickel(II) palmitate; [20]

(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]

(isononanoato-O)(isooctanoato-O)nickel; [22]

(isooctanoato-O)(neodecanoato-O)nickel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]

(isodecanoato-O)(isooctanoato-O)nickel; [26]

(isodecanoato-O)(isononanoato-O)nickel; [27]

(isononanoato-O)(neodecanoato-O)nickel; [28]

fatty acids, C6-19-branched, nickel salts; [29]

fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]

2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]

E, H

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

294-302-1 [29]

283-972-0 [30]

- [31]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9 [25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-055-00-6

nickel(II) sulfite; [1]

nickel tellurium trioxide; [2]

nickel tellurium tetraoxide; [3]

molybdenum nickel hydroxide oxide phosphate [4]

E, H

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-056-00-1

nickel boride (NiB); [1]

dinickel boride; [2]

trinickel boride; [3]

nickel boride; [4]

dinickel silicide; [5]

nickel disilicide; [6]

dinickel phosphide; [7]

nickel boron phosphide [8]

E, H

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-057-00-7

dialuminium nickel tetraoxide; [1]

nickel titanium trioxide; [2]

nickel titanium oxide; [3]

nickel divanadium hexaoxide; [4]

cobalt dimolybdenum nickel octaoxide; [5]

nickel zirkonium trioxide; [6]

molybdenum nickel tetraoxide; [7]

nickel tungsten tetraoxide; [8]

olivine, nickel green; [9]

lithium nickel dioxide; [10]

molybdenum nickel oxide; [11]

E, H

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-058-00-2cobalt lithium nickel oxideE442-750-5

Carc. Cat. 1; R49

T+; R26

T; R48/23

R43

N; R50-53

T+; N

R: 49-26-43-48/23-50/53

S: 53-45-60-61

029-014-00-5

mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;

2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex

419-610-7171866-24-3

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-51/53

S: (2-)22-36-61

030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9R52-53

R: 52/53

S: 61

030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9N; R51-53

N

R: 51/53

S: 61

042-005-00-0

mixture of: mono- and di-glycerols of canola oil;

canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];

N,N-diorgano dithiocarbamate molybdenum complex

434-240-6

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

050-023-00-5

mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;

bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane

422-920-5

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)23-36-60-61

C ≥ 10 %: Xn, N; R48/22-50/53

2,5 % ≤ C < 10 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

050-024-00-0

mixture of: tri-p-tolyltin hydroxide;

hexa-p-tolyl-distannoxane

432-230-6

T; R48/25

Xn; R22

Xi; R38-41

R43

N; R50-53

T; N

R: 22-38-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5N; R51-53

N

R: 51/53

S: 61

078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6

Xn; R22-48/20/21/22

C; R35

R42/43

R52-53

C

R: 22-35-42/43-48/20/21/22-52/53

S: (1/2-)23-24-26-28-36/37/39-45-61

078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1

C; R35

N; R50-53

C; N

R: 35-50/53

S: (1/2-)26-36/37/39-45-60-61

082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5

Xn; R22-48/22

N; R51-53

Xn; N

R: 22-48/22-51/53

S: (2-)22-36-61

601-080-00-5

mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;

1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;

1-(sec-butylphenyl-1-phenylethane, mixed isomers

431-100-6N; R50-53

N

R: 50/53

S: 60-61

601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)36/37-61

601-082-00-6

mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;

exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane

434-420-4

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)23-26-37/39-57-60-61

601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3

Xn; R65

Xi; R38

R53

Xn

R: 38-65-53

S: (2-)37-62-61

601-084-00-7

mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;

5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)

435-180-3

Xn; R65

Xi; R38

N; R50-53

Xn; N

R: 38-65-50/53

S: (2-)37-62-60-61

602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-61

602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3

Xn; R22

Xi; R38

N; R51-53

Xn; N

R: 22-38-51/53

S: (2-)37-61

602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2

Xn; R22

Xi; R36

R43

Xn

R: 22-36-43

S: (2-)26-36/37

603-211-00-1

2,3-epoxypropyltrimethylammonium chloride … %;

glycidyl trimethylammonium chloride … %

B E221-221-03033-77-0

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

Xn; R21/22-48/22

Xi; R41

R43

R52-53

T

R: 45-21/22-41-43-48/22-62-68-52/53

S: 53-45-61

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;

galaxolide;

(HHCB)

214-946-91222-05-5N; R50-53

N

R: 50/53

S: 60-61

603-213-00-2

2-methoxy-2-methylbutane;

tert-amyl methyl ether

213-611-4994-05-8

F; R11

Xn; R22

R67

F; Xn

R: 11-22-67

S: (2-)9-16-23-33

603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2C; R34

C

R: 34

S: (1/2-)23-26-36/37/39-45

603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0

E; R2

Xn; R22-48/22

Xi; R41

R43

N; R50-53

E; Xn; N

R: 2-22-41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4

R43

R53

Xi

R: 43-53

S: (2-)24-37/39-61

603-220-00-01-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3R53

R: 53

S: 61

603-221-00-6

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2214353-17-0

Xn; R22

C; R34

N; R51-53

C; N

R: 22-34-51/53

S: (1/2-)26-36/37/39-45-61

603-221-01-3

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]

E433-580-2214353-17-0

Carc. Cat. 2; R45

Xn; R22

C; R34

N; R51-53

T; N

R: 45-22-34-51/53

S: 53-45-61

603-222-00-1(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Xi; R36

Xi

R: 36

S: (2-)26

603-223-00-7

2-cyclopentylidene cyclopentanol;

1,1′-bi(cyclopentyliden)-2-ol

434-270-16261-30-9

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9R53

R: 53

S: 61

603-225-00-8

erythromycin A9-oxime (E);

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)

437-070-013127-18-9N; R51-53

N

R: 51/53

S: 61

603-226-00-34,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2R52-53

R: 52/53

S: 61

603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);

reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate

445-060-2203574-04-3

O; R7

N; R50-53

O; N

R: 7-50/53

S: (2-)3/7-14-36/37/39-60-61

603-228-00-4

(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;

6-fluoro-2-(2-oxiranyl)chromane

419-620-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)36/37-61

603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61

603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5

Xi; R38-41

R53

Xi

R: 38-41-53

S: (2-)26-37/39-61

603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6R52-53

R: 52/53

S: 22-61

603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6R53

R: 53

S: 61

603-233-00-1

mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0N; R51-53

N

R: 51/53

S: 61

603-234-00-7(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

604-074-00-0

tetrabromobisphenol-A;

2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol

201-236-979-94-7N; R50-53

N

R: 50/53

S: 60-61

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;

4-tert-octylphenol

205-426-2140-66-9

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61

C ≥ 20 %: Xi, N; R38-41-50/53

10 % ≤ C < 20 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

604-076-00-1phenolphthalein201-004-777-09-8

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T

R: 45-62-68

S: 53-45

C ≥ 5 %: T; R45-62-68

1 % ≤ C < 5 %: T; R45-68

604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6R53

R: 53

S: 61

604-079-00-84,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0

Repr.Cat.3; R62

R43

N; R51-53

Xn; N

R: 43-62-51/53

S: (2-)22-36/37-61

604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1

Xn; R20

C; R35

R43

N; R51-53

C; N

R: 20-35-43-51/53

S: (1/2-)26-28-36/37/39-45-61

604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1N; R50-53

N

R: 50/53

S: 25-60-61

604-082-00-42-chloro-6-fluoro-phenolE433-890-82040-90-6

Muta.Cat.2; R46

Repr.Cat.3; R62

Xn; R22

C; R34

R43

N; R51-53

T; N

R: 46-22-34-43-62-51/53

S: 53-45-61

604-083-00-X4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol439-270-3260408-02-4R53

R: 53

S: 61

604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)23-61

604-087-00-1

mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol

433-640-8

F; R17

R44

R53

F

R: 17-44-53

S: (2-)15-22-61

604-089-00-22-methyl-5-tert-butylthiophenol444-970-7

R10

Repr.Cat.3; R63

Xn; R48/20/22-65

Xi; R36/38

R43

R67

N; R50-53

Xn; N

R: 10-36/38-43-48/20/22-63-65-67-50/53

S: (2-)26-36/37-62-60-61

605-037-00-1

trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;

3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde

421-800-1120578-03-2R53

R: 53

S: 22-61

605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4

Xn; R22

Xi; R38

R43

N; R51-53

Xn; N

R: 22-38-43-51/53

S: (2-)36/37-61

605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0

Xn; R22

Xi; R41

R43

Xn

R: 22-41-43

S: (2-)22-24-26-37/39

606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)36-60-61

606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Xn; R22

Xn

R: 22

S: (2-)22

606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7N; R51-53

N

R: 51/53

S: 61

606-128-00-92,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8R53

R: 53

S: 61

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;

(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one

423-090-7156732-13-7R53

R: 53

S: 61

606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dioneE427-230-85571-36-8

Repr. Cat. 2; R60

Xn; R48/22

N; R51-53

T; N

R: 60-48/22-51/53

S: 53-45-61

606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. Cat.3; R62

Xn

R: 62

S: (2-)22-36/37

606-135-00-7cyclohexadecanone438-930-82550-52-9R53

R: 53

S: 61

606-136-00-2(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4

Xi; R36

R53

Xi

R: 36-53

S: (2-)26-61

606-137-00-8 trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione444-750-0211387-26-7R53

R: 53

S: 22-61

606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0

R10

Xn; R22-48/22

Xi; R38-41

R43

N; R50-53

Xn; N

R: 10-22-38-41-43-48/22-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53

20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53

10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9R53

R: 53

S: 61

606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7Xi; R36

Xi

R: 36

S: (2-)26

606-142-00-5

mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one

434-290-9

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)61

607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)22-24-37-61

607-618-00-5

menadione sodium bisulfite;

2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt

204-987-0130-37-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-619-00-0

menadione nicotinamide bisulfite;

1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)

277-543-773581-79-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3

Carc. Cat. 3; R40

Xn; R22

Xi; R36

Xn

R: 22-36-40

S: (2-)26-36/37-46

C ≥ 25 %: Xn; R22-36-40

20 ≤ % C < 25 %: Xn; R36-40

5 ≤ % C < 20 %: Xn; R40

607-621-00-1

milbemectin (ISO);

[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]

Xn; R20/22

N; R50-53

Xn; N

R: 20/22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R20/22-50/53

0,25 % ≤ C < 25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. Cat. 3; R63

Xn

R: 63

S: (2-)36/37

607-623-00-2diisobutyl phthalate201-553-284-69-5

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T

R: 61-62

S: 53-45

C ≥ 25 %: T; R61-62

5 % ≤ C < 25 %: Xn; R62

607-624-00-8

perfluorooctane sulfonic acid;

heptadecafluorooctane-1-sulfonic acid; [1]

potassium perfluorooctanesulfonate;

potassium heptadecafluorooctane-1-sulfonate; [2]

diethanolamine perfluorooctane sulfonate; [3]

ammonium perfluorooctane sulfonate;

ammonium heptadecafluorooctanesulfonate; [4]

lithium perfluorooctane sulfonate;

lithium heptadecafluorooctanesulfonate [5]

E

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. Cat. 3; R40

Repr. Cat. 2; R61

T; R48/25

Xn; R20/22

R64

N; R51-53

T; N

R: 61-20/22-40-48/25-64-51/53

S: 53-45-61

607-625-00-3clodinafop-propargyl (ISO)105512-06-9

Xn; R22-48/22

R43

N; R50-53.

Xn; N

R: 22-43-48/22-50/53

S: (2-)24-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53

2,5 % ≤ C < 10 %: Xi, N; R43-51/53

0,25 % ≤ C < 2,5 %: Xi; R43-52/53

0,001 % ≤ C < 0,25 %: Xi; R43

607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2

Carc.Cat.2; R45

N; R50-53

T; N

R: 45-50/53

S: 53-45-60-61

607-627-00-4[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5R43

Xi

R: 43

S: (2-)22-24-37

607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Xi; R41

Xi

R: 41

S: (2-)26-39

607-629-00-5[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid419-270-1123599-82-6Xi; R36

Xi

R: 36

S: (2-)26

607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6

Xn; R20

C; R34

R43

R52-53

C

R: 20-34-43-52/53

S: (1/2-)26-36/37/39-45-61

607-631-00-6

mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;

(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate

442-300-8R43

Xi

R: 43

S: (2-)24-37

607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5R53

R: 53

S: 61

607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

607-634-00-2

(S)-(-)-2-acetoxypropionylchloride;

(1S)-2-chloro-1-methyl-2-oxoethyl acetate

420-610-436394-75-9

Xn; R22

C; R34

R43

C

R: 22-34-43

S: (1/2-)23-26-36/37/39-45

607-635-00-8trisodium N-(3-propionato)-L-aspartate422-090-4172737-80-3Xi; R41

Xi

R: 41

S: (2-)26-39

607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8

R10

Carc.Cat.3; R40

C; R34

R43

C

R: 10-34-40-43

S: (1/2-)7/9-8-23-26-36/37/39-45

607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate423-730-5250688-43-8Xi; R41

Xi

R: 41

S: (2-)26-39

607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7R53

R: 53

S: 61

607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6R53

R: 53

S: 61

607-641-00-0

2-(formylamino)-3-thiophenecarboxylic acid;

2-formamido-3-thiophenecarboxylic acid

431-930-943028-69-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)22-24-37

607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3N; R50-53

N

R: 50/53

S: 60-61

607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0

R10

Xi; R41

R43

Xi

R: 10-41-43

S: (2-)24-26-37/39-43

607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Xi; R38

Xi

R: 38

S: (2-)37

607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-646-00-8

D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;

tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate

432-960-5124655-09-0Xn; R22

Xn

R: 22

S: (2-)25

607-647-00-35-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5

Xn; R22

R43

N; R50

Xn; N

R: 22-43-50

S: (2-)24-37-57-61

607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8

C; R35

R43

C

R: 35-43

S: (1/2-)7/8-26-36/37/39-45

607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2R43

Xi

R: 43

S: (2-)24-37

607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-652-00-0ethyl N 2-dodecanoyl-L-argininate hydrochloride434-630-660372-77-2

Xi; R41

N; R50

Xi; N

R: 41-50

S: (2-)26-39-61

607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4N; R51-53

N

R: 51/53

S: 61

607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4R43

Xi

R: 43

S: (2-)23-24-37

607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-661-00-X1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6

R43

R53

Xi

R: 43-53

S: (2-)22-24-37-61

607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3R53

R: 53

S: 61

607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)26-39-61

607-665-00-1 trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1R10

R: 10

S: 23

607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Xi; R36

Xi

R: 36

S: (2-)26

607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2

Muta.Cat.3; R68

R43

Xn

R: 43-68

S: (2-)23-36/37

607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;

(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate

448-700-9500791-70-8

Xn; R48/22

Xi; R41

R43

N; R50-53

Xn; N

R: 41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

C ≥ 10 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6N; R51-53

N

R: 51/53

S: 61

607-672-00-X

mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;

1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;

x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate

419-000-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

607-674-00-0branched C10-alkyl benzoates421-090-1131298-44-7Xn; R20

Xn

R: 20

S: (2-)23

607-675-00-6

mixture of: cis-9-octadecenedioic acid;

cis-9-cis-12-octadecadienedioic acid;

hexadecanedioic acid;

octadecanedioic acid

422-260-8

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

607-676-00-1

mixture of: 2-methylnonanedioic acid;

2,4-dimethyl-4-methoxycarbonylundecanedioic acid;

2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;

8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid

423-670-1

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-677-00-72,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate424-660-8

Xn; R48/22

Xi; R41

R43

Xn

R: 41-43-48/22

S: (2-)22-26-36/37/39

607-678-00-2

mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;

ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate

427-090-8

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)23-25-36/37-61

607-679-00-8

mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);

3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);

3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)

431-440-5

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)22-26-39-61

607-680-00-3 tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9R53

R: 53

S: 61

607-681-00-9

mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;

9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;

dihexadecyl 9-nonyl-10-octylnonadecandioate;

1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;

dioctadecyl 9-nonyl-10-octylnonadecandioate

432-910-2R53

R: 53

S: 61

607-682-00-4complex mixture of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9R53

R: 53

S: 61

607-683-00-X

mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)

435-450-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1

Xi; R38

R43

Xi

R: 38-43

S: (2-)24-37

607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7Xi; R38-41

Xi

R: 38-41

S: (2-)26-37/39

607-686-00-66,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5

E; R2

F; R11

Carc. Cat. 3; R40

E; Xn

R: 2-11-40

S: (2-)7-22-36/37

607-687-00-1

mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)

442-800-6

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2Xn; R22

Xn

R: 22

S: (2-)

607-689-00-2

mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);

methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)

444-920-4R52-53

R: 52/53

S: 61

607-690-00-8dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3R43

Xi

R: 43

S: (2-)24-37

607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6R53

R: 53

S: 61

607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4R53

R: 53

S: 61

607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7R53

R: 53

S: 61

607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-36/37-60-61

608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2

Xn; R22

Xi; R41

R43

N; R51-53

Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61

608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3N; R51-53

N

R: 51/53

S: 22-61

608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7N; R50-53

N

R: 50/53

S: 22-60-61

608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4

T; R25

Xi; R41

R43

N; R50-53

T; N

R: 25-41-43-50/53

S: (1/2-)9-26-36/37/39-45-60-61

608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2R52-53

R: 52/53

S: 61

609-069-00-7

musk ketone;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;

4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone

201-328-981-14-1

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61

611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3R52-53

R: 52/53

S: 61

611-155-00-44,4′-oxybis(benzenesulfonylazide)431-850-47456-68-0

E; R3

F; R11

Xn; R48/22

N; R50-53

E; Xn; N

R: 3-11-48/22-50/53

S: (2-)14-22-33-35-36-60-61

611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6

Repr. Cat. 3; R62

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-62-51/53

S: (2-)36/37-61

611-157-00-5

benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;

potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate

432-590-4243869-48-9

Xi; R36

R52-53

Xi

R: 36-52/53

S: (2-)26-61

611-158-00-0reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride421-520-8

F; R11

R53

F

R: 11-53

S: (2-)3-12-16-33-61

611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-160-00-1

mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;

1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)

422-760-6

F; R11

R53

F

R: 11-53

S: (2-)3-12-33-61

611-161-00-7trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)423-100-1Xi; R41

Xi

R: 41

S: (2-)26-39

611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-164-00-3

mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;

2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2,2′-dimethyl-2,2′-azoheptanenitrile;

2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)

429-710-2

R10

R32

R44

Xn; R22

N; R51-53

Xn; N

R: 10-22-32-44-51/53

S: (2-)12-15-16-47-51-61

611-165-00-9

mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;

tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

431-830-5R52-53

R: 52/53

S: 61

611-166-00-4

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

432-100-9

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)435-240-9R52-53

R: 52/53

S: 61

611-168-00-5

mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;

3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid

435-440-6Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2R52-53

R: 52/53

S: 61

611-170-00-6

mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);

disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)

435-880-9R52-53

R: 52/53

S: 22-61

611-171-00-1

mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;

trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate

436-890-6

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-172-00-7

mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;

diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

438-310-7

E; R2

Repr. Cat. 3; R62

Xn; R22-48/22

R52-53

E; Xn

R: 2-22-48/22-62-52/53

S: (2-)22-35-36/37-61

611-173-00-2

mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;

3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt

440-510-4

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-26-36/37/39

611-174-00-8

mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt

442-290-5457624-86-1Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-175-00-3

mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate

444-050-5

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2

E; R2

F; R11

N; R51-53

E; N

R: 2-11-51/53

S: (2-)22-61

611-177-00-4

mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)

444-290-0508202-43-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-37/39-61

611-178-00-X

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

445-280-9

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

611-179-00-5

mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;

2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts417-850-7N; R51-53

N

R: 51/53

S: 22-61

612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %B222-048-33327-22-8

Carc. Cat. 3, R40

R52-53

Xn

R: 40-52/53

S: 36/37-61

612-239-00-3

biphenyl-3,3′,4,4′-tetrayltetraamine;

diaminobenzidine

202-110-691-95-2

Carc. Cat. 2; R45

Muta. Cat. 3; R68

T

R: 45-68

S: 53-45

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)aniline

53112-28-0N; R51-53

N

R: 51/53

S: 61

612-241-00-4

piperazine hydrochloride; [1]

piperazine dihydrochloride; [2]

piperazine phosphate [3]

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. Cat. 3; R62-63

Xi; R36/38

R42/43

R52-53

Xn

R: 36/38-42/43-62-63-52/53

S: (1/2-)22-36/37-45-63-61

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine

121552-61-2

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

C ≥ 10 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2, 5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1

Repr. Cat. 3; R62

Xn; R22

Xi; R36

R43

N; R50-53

Xn; N

R: 22-36-43-62-50/53

S: (2-)22-26-36/37/39-60-61

612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2

Carc. Cat. 3; R40

T; R48/25

Xn; R22

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53

10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53

5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chlorideE429-740-640722-80-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/22

R43

R52-53

T

R: 45-46-43-48/22-52/53

S: 53-45-61

612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4

T; R48/25

Xn; R22

R52-53

T

R: 22-48/25-52/53

S: (1/2-)22-36-45-61

612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)24-37-61

612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2

Repr. Cat. 3; R62

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-43-62-51/53

S: (1/2-)22-26-36/37/39-45-61

612-250-00-3chloro-N,N-dimethylformiminium chlorideE425-970-63724-43-4

R14

Repr. Cat. 2; R61

Xn; R22

C; R35

T; C

R: 61-14-22-35

S: 53-45

612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8

F; R11

Repr. Cat. 3; R63

Xn; R22

Xi; R38

R43

N; R51-53

F; Xn; N

R: 11-22-38-43-63-51/53

S: (2-)7-22-33-36/37-61

612-252-00-4

imidacloprid (ISO);

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine

428-040-8138261-41-3

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)22-57-60-61

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing < 0,5 % formamide (EC No 200-842-0)]

429-400-7199327-61-2R52-53

R: R52/53

S: 61

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing ≥ 0,5 % formamide (EC No 200-842-0)]

429-400-7199327-61-2

Repr. Cat. 2; R61

R52-53

T

R: 61-52/53

S: 53-45-61

612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5

Carc. Cat. 3; R40

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-40-43-51/53

S: (1/2-)13-25-26-36/37/39-45-61

612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4

Xn; R21/22

C; R34

R52-53

C

R: 21/22-34-52/53

S: (1/2-)26-36/37/39-45-61

612-256-00-6benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3

Xn; R22

R43

Xn

R: 22-43

S: (2-)36/37

612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Xn; R22

Xn

R: 22

S: (2-)22

612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Xi; R41

Xi

R: 41

S: (2-)26-39

612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7R52-53

R: 52/53

S: 61

612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0

Muta. Cat. 3; R68

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-68-50/53

S: (2-)22-36/37-60-61

612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0

R43

R53

Xi

R: 43-53

S: (2-)36/37-61

612-269-00-7

mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;

mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline

420-720-2R53

R: 53

S: 22-61

612-270-00-2(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2

Xn; R22

R43

R52-53

Xn

R: 22-43-52/53

S: (2-)22-36/37-61

612-271-00-8

mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;

ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate

434-970-5160987-57-5R53

R: 53

S: 61

612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate435-210-5N; R51-53

N

R: 51/53

S: 61

612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8

Xn; R22

C; R35

N; R50-53

C; N

R: 22-35-50/53

S: (1/2-)26-36/37/39-45-60-61

612-274-00-4(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-24-26-37/39-61

612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 20 %: Xi, N; R38-41-43-50/53

10 % ≤ C < 20 %: Xi, N; R41-43-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-36/37/39-61

612-277-00-0

mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;

4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium

451-440-9586372-44-3Xi; R41

Xi

R: 41

S: (2-)22-26-39

612-278-00-6

ethidium bromide;

3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

214-984-61239-45-8

Muta. Cat. 3; R68

T+; R26

Xn; R22

T+

R: 22-26-68

S: (1/2-)28-36/37-45-63

612-279-00-1(R,S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8

Repr. Cat. 3; R62

Xn; R48/22

Xi; R36/38

R43

Xn

R: 36/38-43-48/22-62

S: (2-)22-26-36/37

612-280-00-7

3-amino-9-ethyl carbazole;

9-ethylcarbazol-3-ylamine

H205-057-7132-32-1Carc. Cat. 2; R45

T

R: 45

S: 53-45

613-116-01-4

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

211-986-9731-27-1

Xi; R36/37/38

R43

N; R50

Xi; N

R: 36/37/38-43-50

S: (2-)25-36/37-46-61

C ≥ 20 %: Xi, N; R36/37/38-43-50

2,5 % ≤ C < 20 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;

dimethyl propyleneurea

230-625-67226-23-5

Repr. Cat. 3; R62

Xn; R22

Xi; R41

Xn

R: 22-41-62

S: 26-36/37/39

613-281-00-5quinolineE202-051-691-22-5

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R21/22

Xi; R36/38

N; R51-53

T; N

R: 45-21/22-36/38-68-51/53

S: 53-45-61

613-282-00-0

triticonazole (ISO);

(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

131983-72-7N; R51-53

N

R: 51/53

S: 61

613-283-00-6

ketoconazole;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

E265-667-465277-42-1

Repr. Cat. 2; R60

T; R25

Xn; R48/22

N; R50-53

T; N

R: 60-25-48/22-50/53

S: 53-45-60-61

613-284-00-1

metconazole (ISO);

(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

125116-23-6

Repr. Cat. 3; R63

Xn; R22

N; R51-53

Xn; N

R: 22-63-51/53

S: (2-)36/37-46-61

613-285-00-7

1-hydroxybenzotriazole, anhydrous; [1]

1-hydroxybenzotriazole, monohydrated [2]

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

E; R2

E

R: 2

S: 16-35

613-286-00-2

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2183196-57-8R43

Xi

R: 43

S: (2-)24-37

613-286-01-X

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2183196-57-8

Repr. Cat. 2; R61

R43

T

R: 61-43

S: 53-45

613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-37/39-61

613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1N; R50-53

N

R: 50/53

S: 60-61

613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61

613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one434-820-9106461-41-0

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

613-292-00-5 N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3

Muta. Cat. 3; R68

R52-53

Xn

R: 68-52/53

S: (2-)36/37-61

613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester448-050-6444065-11-6R53

R: 53

S: 61

613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9R53

R: 53

S: 61

613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride448-720-8363138-44-7

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-39-61

613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate418-270-7

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-47-61

613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6

R10

Xn; R22

N; R51-53

Xn; N

R: 10-22-51/53

S: (2-)16-61

613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate421-560-6

Xn; R48/22

Xi; R41

N; R51-53

Xn; N

R: 41-48/22-51/53

S: (2-)22-26-36/39-61

613-299-00-3

main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt

422-610-1Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate443-910-7R53

R: 53

S: 61

613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1N; R50-53

N

R: 50/53

S: 60-61

613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7

Xn; R22

Xi; R41

Xn

R: 22-41

S: (2-)22-26-39

613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1R53

R: 53

S: 61

613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-307-00-5

clothianidin (ISO);

3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine

210880-92-5

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R22-50/53

2,5 % ≤ C < 25 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

613-308-00-02-amino-5-methylthiazole423-800-57305-71-7

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-50/53

S: (2-)22-36-60-61

613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2

Xn; R21/22

Xi; R38-41

R52-53

Xn

R: 21/22-38-41-52/53

S: (2-)26-36/37/39-61

613-310-00-1(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride432-360-3105813-13-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61

613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6

Xn; R22

Xi; R36

R43

R52-53

Xn

R: 22-36-43-52/53

S: (2-)22-24-26-37-61

613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-26-36/37/39-61

613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione442-780-9173838-67-0R52-53

R: 52/53

S: 61

613-314-00-3

4-decyloxazolidin-2-one;

4-decyl-1,3-oxazolidin-2-one

443-770-77693-82-5N; R50-53

N

R: 50/53

S: 22-24-60-61

613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1

Xn; R20

R52-53

Xn

R: 20-52/53

S: (2-)25-61

613-316-00-4

trimethylopropane tri(3-aziridinylpropanoate);

(TAZ)

H257-765-052234-82-9

Muta. Cat. 3; R68

Xi; R41

R43

Xn

R: 41-43-68

S: 26-36/37/39-42

615-044-00-14-chlorophenylisocyanate203-176-9104-12-1

T+; R26

Xn; R22

Xi; R37/38-41

R42

N; R50-53

T+; N

R: 22-26-37/38-41-42-50/53

S: (1/2-)26-28-36/37/39-45-63-60-61

615-045-00-74,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1

R42/43

R53

Xn

R: 42/43-53

S: (2-)23-24-37-45-61

616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36/37-61

616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide

149961-52-4

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20

N; R50-53

Xn; N

R: 20-40-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-40-63-50/53

5 % ≤ C < 25 %: Xn, N; R40-63-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52-53

616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide

113614-08-7N; R50-53

N

R: 50/53

S: 60-61

C ≥ 0,25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

616-166-00-8

cyazofamid (ISO);

4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide

120116-88-3N; R50-53

N

R: 50/53

S: 60-61

C ≥ 2,5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51-53

0,025 % ≤ C < 0,25 %: R52/53

616-167-00-3 N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4

Xi; R36

R43

Xi

R: 36-43

S: (2-)24-26-37

616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2R43

Xi

R: 43

S: (2-)22-24-37

616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2

Xi; R36

R43

Xi

R: 36-43

S: (2-)22-26-36/37

616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

616-172-00-0

N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;

(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

423-840-314691-89-5Xn; R22

Xn

R: 22

S: (2-)22

616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1

Xn; R22

Xi; R36

Xn

R: 22-36

S: (2-)22-26

616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3R53

R: 53

S: 61

616-176-00-23-N,N-bis(methoxyethyl)aminoacetanilide432-530-724294-01-7

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)22-24-61

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide

432-970-1217324-98-6R53

R: 53

S: 61

616-178-00-3 N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4R53

R: 53

S: 22-61

616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)22-26-36/37/39-60-61

616-180-00-4 N,N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9

Repr. Cat. 2; R61

N; R50-53

T; N

R: 61-50/53

S: 53-45-60-61

616-181-00-X4′-methyldodecane-1-sulfonanilide435-490-917417-32-2N; R50-53

N

R: 50/53

S: 60-61

616-182-00-5 N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

616-183-00-0 N-dodecyl-4-methoxybenzamide442-340-61854-15-5R53

R: 53

S: 61

616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8R53

R: 53

S: 61

616-186-00-7 N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4R52-53

R: 52/53

S: 61

616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-189-00-3 N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9R53

R: 53

S: 61

616-190-00-9 N-decyl-4-nitrobenzamide445-880-064026-19-3R53

R: 53

S: 61

616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0

Xn; R22

Xi; R36/38

R43

N; R51-53

Xn; N

R: 22-36/38-43-51/53

S: (2-)24-26-37-61

616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9R53

R: 53

S: 61

616-193-00-5 N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9R53

R: 53

S: 61

616-194-00-02,2-diethoxy-N,N-dimethylacetamide449-950-134640-92-1Xi; R36

Xi

R: 36

S: (2-)26

616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide419-990-4N; R50-53

N

R: 50/53

S: 60-61

616-197-00-7

mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide

422-500-1Xn; R48/22

Xn

R: 48/22

S: (2-)22-36

616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-200-00-1

mixture of: N,N′-ethane-1,2-diylbis(hexanamide);

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;

N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)

432-430-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6

Xn; R20

R53

Xn

R: 20-53

S: (2-)22-61

616-202-00-2

mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide

434-330-5

Carc. Cat. 3; R40

R43

R53

Xn

R: 40-43-53

S: (2-)36/37-61

616-203-00-8

mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide

442-280-0R53

R: 53

S: 61

616-204-00-3 N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]451-060-3122886-55-9R53

R: 53

S: 61

617-022-00-7

mixture of: 1,2-dimethylpropylidene dihydroperoxide;

dimethyl 1,2-benzenedicarboxylate

442-480-8

O; R7

Xn; R22

C; R34

R43

N; R51-53

O; C; N

R: 7-22-34-43-51/53

S: (1/2-)3/7-14-26-36/37/39-45-50-61

647-017-00-5laccase420-150-480498-15-3R42

Xn

R: 42

S: (2-)23-45

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources